Janus Henderson Biotech Innovation Fund II Ltd · CIK 2034032
Janus Henderson Biotech Innovation Fund II Ltd
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
0
Amendments
1
Activity
Aug 18, 2025
through Aug 18, 2025
through Aug 18, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $402,000,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Likely investment adviser (not guaranteed)
Best-effort name match against Form ADV. Click through for AUM, employees, and disciplinary disclosures.
-
JANUS HENDERSON INVESTORS US LLC
high CRD 801-13991
Similar issuer names (identity not confirmed)
- Janus Henderson Biotech Innovation Fund II LLC CIK 2122350 · Delaware
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Aerospace Opportunity Fund, L.P. · CIK 2097936
- Ascent Crossover Opportunity Fund III Follow-On Vehicle, L.P · CIK 2161785
- Ascent Crossover Opportunity Fund III, L.P. · CIK 2137873
- Ascent Crossover Opportunity Offshore Fund III, L.P. · CIK 2137872
- Janus Henderson ANTIK Ventures Master Fund I, L.P. · CIK 2110413
Form D filings (1)
-
0002034032-25-000002D/A · Aug 18, 2025 · Pooled Investment FundSold: $402,000,000